N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide

C112H148N53O14S6+ — CID 159680984

IUPACN-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide
SMILESCN(Cc1ccccc1)c1ccnc(S(C)(=O)=O)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(CN3CCOCC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(N3CC[C@H](O)C3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(c3cnc4n3CCCC4)CC2)c1-c1nn[nH]n1.Cn1cncc1C1CCN(c2ccnc(S(C)(=O)=O)c2-c2nn[nH]n2)CC1.NS(=O)(=O)c1nccc(N2CCC(N3CCCCC3)CC2)c1-c1nn[nH]n1.c1c[n+](C2CCN(n3ccnc3)CC2)c(-c2nn[nH]n2)cn1
InChIInChI=1S/C19H24N8O2S.C17H25N7O3S.C16H20N8O2S.C16H24N8O2S.C16H23N7O3S.C15H16N6O2S.C13H15N9/c1-30(28,29)19-17(18-22-24-25-23-18)14(5-8-20-19)26-10-6-13(7-11-26)15-12-21-16-4-2-3-9-27(15)16;1-28(25,26)17-15(16-19-21-22-20-16)14(2-5-18-17)24-6-3-13(4-7-24)12-23-8-10-27-11-9-23;1-23-10-17-9-13(23)11-4-7-24(8-5-11)12-3-6-18-16(27(2,25)26)14(12)15-19-21-22-20-15;17-27(25,26)16-14(15-19-21-22-20-15)13(4-7-18-16)24-10-5-12(6-11-24)23-8-2-1-3-9-23;1-27(25,26)16-14(15-18-20-21-19-15)13(2-6-17-16)22-7-3-11(4-8-22)23-9-5-12(24)10-23;1-21(10-11-6-4-3-5-7-11)12-8-9-16-15(24(2,22)23)13(12)14-17-19-20-18-14;1-5-20(21-7-3-15-10-21)6-2-11(1)22-8-4-14-9-12(22)13-16-18-19-17-13/h5,8,12-13H,2-4,6-7,9-11H2,1H3,(H,22,23,24,25);2,5,13H,3-4,6-12H2,1H3,(H,19,20,21,22);3,6,9-11H,4-5,7-8H2,1-2H3,(H,19,20,21,22);4,7,12H,1-3,5-6,8-11H2,(H2,17,25,26)(H,19,20,21,22);2,6,11-12,24H,3-5,7-10H2,1H3,(H,18,19,20,21);3-9H,10H2,1-2H3,(H,17,18,19,20);3-4,7-11H,1-2,5-6H2/p+1/t;;;;12-;;/m....0../s1
InChIKeyGWOBUATZBXZVFM-COLMJRQPSA-O
MW2653.17 g/mol
LogP3.66
Rot. Bonds29

About N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide

N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide (PubChem CID 159680984) has the molecular formula C112H148N53O14S6+ and a molecular weight of 2653.17 g/mol. Its IUPAC name is N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide.

Molecular Properties

Compound NameN-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide
PubChem CID159680984
Molecular FormulaC112H148N53O14S6+
Molecular Weight2653.17 g/mol
Exact Mass2651.08
IUPAC NameN-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide
SMILESCN(Cc1ccccc1)c1ccnc(S(C)(=O)=O)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(CN3CCOCC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(N3CC[C@H](O)C3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(c3cnc4n3CCCC4)CC2)c1-c1nn[nH]n1.Cn1cncc1C1CCN(c2ccnc(S(C)(=O)=O)c2-c2nn[nH]n2)CC1.NS(=O)(=O)c1nccc(N2CCC(N3CCCCC3)CC2)c1-c1nn[nH]n1.c1c[n+](C2CCN(n3ccnc3)CC2)c(-c2nn[nH]n2)cn1
InChIInChI=1S/C19H24N8O2S.C17H25N7O3S.C16H20N8O2S.C16H24N8O2S.C16H23N7O3S.C15H16N6O2S.C13H15N9/c1-30(28,29)19-17(18-22-24-25-23-18)14(5-8-20-19)26-10-6-13(7-11-26)15-12-21-16-4-2-3-9-27(15)16;1-28(25,26)17-15(16-19-21-22-20-16)14(2-5-18-17)24-6-3-13(4-7-24)12-23-8-10-27-11-9-23;1-23-10-17-9-13(23)11-4-7-24(8-5-11)12-3-6-18-16(27(2,25)26)14(12)15-19-21-22-20-15;17-27(25,26)16-14(15-19-21-22-20-15)13(4-7-18-16)24-10-5-12(6-11-24)23-8-2-1-3-9-23;1-27(25,26)16-14(15-18-20-21-19-15)13(2-6-17-16)22-7-3-11(4-8-22)23-9-5-12(24)10-23;1-21(10-11-6-4-3-5-7-11)12-8-9-16-15(24(2,22)23)13(12)14-17-19-20-18-14;1-5-20(21-7-3-15-10-21)6-2-11(1)22-8-4-14-9-12(22)13-16-18-19-17-13/h5,8,12-13H,2-4,6-7,9-11H2,1H3,(H,22,23,24,25);2,5,13H,3-4,6-12H2,1H3,(H,19,20,21,22);3,6,9-11H,4-5,7-8H2,1-2H3,(H,19,20,21,22);4,7,12H,1-3,5-6,8-11H2,(H2,17,25,26)(H,19,20,21,22);2,6,11-12,24H,3-5,7-10H2,1H3,(H,18,19,20,21);3-9H,10H2,1-2H3,(H,17,18,19,20);3-4,7-11H,1-2,5-6H2/p+1/t;;;;12-;;/m....0../s1
InChIKeyGWOBUATZBXZVFM-COLMJRQPSA-O
XLogP3.66
TPSA821.51 Ų
H-Bond Donors9
H-Bond Acceptors58
Rotatable Bonds29
Heavy Atoms185
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002653.17
LogP ≤ 53.66
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1058

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide?
The IUPAC name of N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide (CID 159680984) is N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide.
What is the SMILES notation for N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide?
The canonical SMILES for N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide is CN(Cc1ccccc1)c1ccnc(S(C)(=O)=O)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(CN3CCOCC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(N3CC[C@H](O)C3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(N2CCC(c3cnc4n3CCCC4)CC2)c1-c1nn[nH]n1.Cn1cncc1C1CCN(c2ccnc(S(C)(=O)=O)c2-c2nn[nH]n2)CC1.NS(=O)(=O)c1nccc(N2CCC(N3CCCCC3)CC2)c1-c1nn[nH]n1.c1c[n+](C2CCN(n3ccnc3)CC2)c(-c2nn[nH]n2)cn1.
What is the InChIKey of N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide?
The InChIKey is GWOBUATZBXZVFM-COLMJRQPSA-O. The full InChI is InChI=1S/C19H24N8O2S.C17H25N7O3S.C16H20N8O2S.C16H24N8O2S.C16H23N7O3S.C15H16N6O2S.C13H15N9/c1-30(28,29)19-17(18-22-24-25-23-18)14(5-8-20-19)26-10-6-13(7-11-26)15-12-21-16-4-2-3-9-27(15)16;1-28(25,26)17-15(16-19-21-22-20-16)14(2-5-18-17)24-6-3-13(4-7-24)12-23-8-10-27-11-9-23;1-23-10-17-9-13(23)11-4-7-24(8-5-11)12-3-6-18-16(27(2,25)26)14(12)15-19-21-22-20-15;17-27(25,26)16-14(15-19-21-22-20-15)13(4-7-18-16)24-10-5-12(6-11-24)23-8-2-1-3-9-23;1-27(25,26)16-14(15-18-20-21-19-15)13(2-6-17-16)22-7-3-11(4-8-22)23-9-5-12(24)10-23;1-21(10-11-6-4-3-5-7-11)12-8-9-16-15(24(2,22)23)13(12)14-17-19-20-18-14;1-5-20(21-7-3-15-10-21)6-2-11(1)22-8-4-14-9-12(22)13-16-18-19-17-13/h5,8,12-13H,2-4,6-7,9-11H2,1H3,(H,22,23,24,25);2,5,13H,3-4,6-12H2,1H3,(H,19,20,21,22);3,6,9-11H,4-5,7-8H2,1-2H3,(H,19,20,21,22);4,7,12H,1-3,5-6,8-11H2,(H2,17,25,26)(H,19,20,21,22);2,6,11-12,24H,3-5,7-10H2,1H3,(H,18,19,20,21);3-9H,10H2,1-2H3,(H,17,18,19,20);3-4,7-11H,1-2,5-6H2/p+1/t;;;;12-;;/m....0../s1.
What are the key properties of N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide?
N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide has a molecular weight of 2653.17 g/mol, XLogP of 3.66, 29 rotatable bonds, 9 hydrogen bond donors, and 58 hydrogen bond acceptors.
Where does this data come from?
All data for N-benzyl-N-methyl-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridin-4-amine;1-(1-imidazol-1-ylpiperidin-4-yl)-2-(2H-tetrazol-5-yl)pyrazin-1-ium;4-[4-(3-methylimidazol-4-yl)piperidin-1-yl]-2-methylsulfonyl-3-(2H-tetrazol-5-yl)pyridine;4-[[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]methyl]morpholine;(3S)-1-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]pyrrolidin-3-ol;3-[1-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]piperidin-4-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine;4-(4-piperidin-1-ylpiperidin-1-yl)-3-(2H-tetrazol-5-yl)pyridine-2-sulfonamide is sourced from PubChem (CID 159680984), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).